BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16827121)

  • 1. VEGFR-3, VEGF-C and VEGF-D mRNA quantification by RT-PCR in different human cell types.
    Leclers D; Durand K; Cook-Moreau J; Rabinovitch-Chable H; Sturtz FG; Rigaud M
    Anticancer Res; 2006; 26(3A):1885-91. PubMed ID: 16827121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S; Iwasaki A; Shirakusa T; Enatsu S; Kawakami T; Kuroki M; Kuroki M
    Anticancer Res; 2007; 27(6A):3735-41. PubMed ID: 17970036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
    Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
    J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.
    Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K
    Surgery; 2003 Mar; 133(3):300-8. PubMed ID: 12660643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
    Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
    Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.
    Yuanming L; Feng G; Lei T; Ying W
    Arch Med Res; 2007 Jan; 38(1):106-12. PubMed ID: 17174733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative expression of vascular endothelial growth factor family members, VEGF-B, -C and -D, by normal human keratinocytes and fibroblasts.
    Trompezinski S; Berthier-Vergnes O; Denis A; Schmitt D; Viac J
    Exp Dermatol; 2004 Feb; 13(2):98-105. PubMed ID: 15009103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile of vascular endothelial growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser capture microdissection (LCM).
    Jais A; Klein D; Wolfesberger B; Walter I
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):207-14. PubMed ID: 21211854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer.
    Tang RF; Wang SX; Zhang FR; Peng L; Wang SX; Xiao Y; Zhang M
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):460-3. PubMed ID: 16109537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.
    Jenny B; Harrison JA; Baetens D; Tille JC; Burkhardt K; Mottaz H; Kiss JZ; Dietrich PY; De Tribolet N; Pizzolato GP; Pepper MS
    J Pathol; 2006 May; 209(1):34-43. PubMed ID: 16523449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
    Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
    Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
    Yano A; Fujii Y; Iwai A; Kawakami S; Kageyama Y; Kihara K
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6012-7. PubMed ID: 17062674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.